Spasticity refers to feelings of stiffness and a wide range of involuntary muscle spasms (sustained muscle contractions or sudden movements). It is one of the more common symptoms of MS. Spasticity may be as mild as the feeling of tightness of muscles or may be so severe as to produce painful, uncontrollable spasms of extremities, usually of the legs. Spasticity may also produce feelings of pain or tightness in and around joints, and can cause low back pain. Although spasticity can occur in any limb, it is much more common in the legs.
- In flexor spasticity, mostly involving the hamstrings (muscles on the back of the upper leg), and hip flexors (muscles at the top of the upper thigh), the hips and knees are bent and difficult to straighten.
- In extensor spasticity, involving the quadriceps and adductors (muscles on the front and inside of the upper leg), the hips and knees remain straight with the legs very close together or crossed over at the ankles.
Spasticity may be aggravated by sudden movements or position changes, extremes of temperature, humidity or infections, and can even be triggered by tight clothing.
Treatment of spasticity and muscle tightness by medication and physical and occupational therapy is needed to prevent painful and disabling contractures in the hips, knees, ankles, shoulders and elbows. Surgical measures are considered for those rare cases of spasticity that defy all other treatments.
Left untreated, spasticity can lead to serious complications, including contractures (frozen or immobilized joints) and pressure sores (Momentum magazine article). Since these complications also act as spasticity triggers, they can set off a dangerous escalation of symptoms.
Some degree of spasticity can provide benefit, particularly for people who experience significant leg weakness. The spasticity gives their legs some rigidity, making it easier for them to stand, transfer, or walk. The goal of treatment for these individuals is to relieve the spasticity sufficiently to ensure comfort and prevent complications, without taking away the rigidity they need to function.
Because spasticity varies so much from person to person, it must be treated on an individual basis and demands a true partnership between the person with MS, physician, nurse, physical therapist and occupational therapist. Treatment begins with the physician recommending ways to relieve the symptoms, including exercise, medication, changes in daily activities or combinations of these methods. The physician will track the progress and make referrals to other health professionals such as occupational and physical therapists
. Daily stretching and other exercises are often effective in helping to relieve spasticity.
Two major antispasticity medications have good safety records. Neither, however, can cure spasticity or improve muscle coordination or strength.
- Baclofen, the most commonly used medication, is a muscle relaxant that works on nerves in the spinal cord. Common side effects are drowsiness and a feeling of muscle weakness. It can be administered orally or by an implanted pump (intrathecal baclofen). Intrathecal baclofen is used for severe spasticity that cannot be managed with oral medication.
- Tizanidine (Zanaflex®) works quickly to calm spasms and relax tightened muscles. Although it doesn't produce muscle weakness, it often causes sedation and a dry mouth. In some patients, it may lower blood pressure.
Other, less commonly-used medications, include:
- Diazepam (Valium®) is not a "first choice" drug for spasticity because it is sedating and has a potential to create dependence. However, its effects last longer with each dose than baclofen, and physicians may prescribe small doses of at bedtime to relieve spasms that interfere with sleep.
- Dantrolene (Dantrium®) generally used only if other drugs have not been effective. It can produce serious side effects including liver damage and blood abnormalities.
- Phenol — a nerve block agent
- Botulinum toxin (Botox®) injections have been shown to be effective in relieving spasticity in individual muscles for up to three months.
- Clonidine — still considered experimental